Pricing

Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

51-200

Links

Org chart

William Chou

President & CEO

William Chou

Collapse

James M. Wilson

Chief Scientific Advisor

Edgar B. Cale

General Counsel & Corporate Secretary

Samiah Al-Zaidy

VP, Clinical Development

Eden Fucci

VP, Manufacturing Operations

Tiffini Voss

VP, Clinical Development

Stuart Henderson

VP, Corporate Development & Investor Relations

Sue Browne

VP, Biology

Steve Krausert

Vice President, Supply Chain & Planning

Anne Marie Pierce

Finance Operations Specialist

Patricia Elsasser

Director Clinical Operations

Derek Kichula

Senior Director, Engineering & General Manager

Rich Mastropietro

Executive Director, IT

Karl Whitney

Senior Vice President, Global Regulatory Affairs

Samiah A. A.

Vice President Clinical Development

Pamela H.

Vice President Clinical Operations

Chelsea Difebbo Ortiz

Executive Director, Patient Advocacy

Glen Kerker II

Director, Regulatory Operations

Teams

Leadership Team

12 members

Scientific Research and Development

12 members

Clinical Operations and Quality Assurance

9 members

Finance and Administrative Support

5 members

Offices

Similar companies

Kura Oncology

20 followers

Dyne Therapeutics

3 followers

Precigen

3 followers

Arcturus Therapeutics

2 followers

Biocytogen

2 followers

Gamida Cell

2 followers

Fortis Life Sciences

1 follower

Entrada Therapeutics

1 follower

Cabaletta Bio

1 follower

Janux Therapeutics

1 follower

Matica Biotechnology

1 follower

Explore companies